These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36801502)

  • 21. The Detection of Novel Stimulants in Oral Fluid from Users Reporting Ecstasy, Molly and MDMA Ingestion.
    Krotulski AJ; Mohr ALA; Fogarty MF; Logan BK
    J Anal Toxicol; 2018 Oct; 42(8):544-553. PubMed ID: 30371847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An LC-MS/MS methodological approach to the analysis of hair for amphetamine-type-stimulant (ATS) drugs, including selected synthetic cathinones and piperazines.
    Lendoiro E; Jiménez-Morigosa C; Cruz A; Páramo M; López-Rivadulla M; de Castro A
    Drug Test Anal; 2017 Jan; 9(1):96-105. PubMed ID: 26914712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A snapshot on NPS in Italy: Distribution of drugs in seized materials analysed in an Italian forensic laboratory in the period 2013-2015.
    Odoardi S; Romolo FS; Strano-Rossi S
    Forensic Sci Int; 2016 Aug; 265():116-20. PubMed ID: 26874736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
    Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
    Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiresidual analysis of emerging amphetamine-like psychoactive substances in wastewater and river water.
    Senta I; Krizman I; Ahel M; Terzic S
    J Chromatogr A; 2015 Dec; 1425():204-12. PubMed ID: 26607313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of ecstasy tablets: comparison of reflectance and transmittance near infrared spectroscopy.
    Schneider RC; Kovar KA
    Forensic Sci Int; 2003 Jul; 134(2-3):187-95. PubMed ID: 12850416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target analysis of psychoactive drugs in oral fluid by QuEChERS extraction and LC-MS/MS.
    Júnior EF; Bitencourt VS; Souza ÁBM; Caldas ED
    J Pharm Biomed Anal; 2024 Jul; 244():116139. PubMed ID: 38608509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The targeted analysis of New Psychoactive Substances in oral fluid through chromatographic-spectrometric methods: review of recent findings.
    Di Trana A; Berardinelli D; Tini A; Zaami S
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):750-754. PubMed ID: 35179740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016-2019.
    Palamar JJ; Salomone A
    Am J Addict; 2021 Jan; 30(1):49-54. PubMed ID: 32813326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Portable near infrared spectroscopy for the isomeric differentiation of new psychoactive substances.
    Kranenburg RF; Ramaker HJ; van Asten AC
    Forensic Sci Int; 2022 Dec; 341():111467. PubMed ID: 36154979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic cathinones - From natural plant stimulant to new drug of abuse.
    Pieprzyca E; Skowronek R; Nižnanský Ľ; Czekaj P
    Eur J Pharmacol; 2020 May; 875():173012. PubMed ID: 32087255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
    Dickson AJ; Vorce SP; Holler JM; Lyons TP
    J Anal Toxicol; 2010 Oct; 34(8):464-9. PubMed ID: 21819791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
    Rousis N; Bade R; Romero-Sánchez I; Mueller JF; Thomaidis NS; Thomas KV; Gracia-Lor E
    Environ Int; 2023 Aug; 178():108075. PubMed ID: 37399770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seized drug reporting of NPS helps to guide regional toxicological practice: A 17 month review between 2022 and 2023.
    Ellefsen KN; Papsun DM; Mata DC; Ayala JL; Modell C; Goodson LJ; Truver MT
    J Forensic Sci; 2024 Jul; 69(4):1392-1399. PubMed ID: 38853356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical and statistical analyses of blotter paper matrix drugs seized in the State of Rio de Janeiro.
    Meira VL; de Oliveira AS; Cohen LSA; de A Bhering C; de Oliveira KM; de Siqueira DS; de Oliveira MAM; Aquino Neto FR; Vanini G
    Forensic Sci Int; 2021 Jan; 318():110588. PubMed ID: 33278694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
    Kalasinsky KS; Hugel J; Kish SJ
    J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
    Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
    Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impurity profiling of ecstasy tablets seized in Hong Kong by gas chromatography-mass spectrometry.
    Cheng JY; Chan MF; Chan TW; Hung MY
    Forensic Sci Int; 2006 Oct; 162(1-3):87-94. PubMed ID: 16860955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.
    Brunt TM; Koeter MW; Niesink RJ; van den Brink W
    Psychopharmacology (Berl); 2012 Apr; 220(4):751-62. PubMed ID: 21993879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic cathinones: an evolving class of new psychoactive substances.
    Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS
    Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.